Earnings Per Share
Shares (Basic)
Neurocrine Biosciences Shares (Basic) increased by 50150.0% to 100.5M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.8%, from 99.7M to 100.5M. Over 3 years (FY 2021 to FY 2025), Shares (Basic) shows relatively stable performance with a 1.7% CAGR.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Changes reflect share buybacks (decrease) or equity issuance (increase), which impact the per-share earnings calculation.
Detailed definition
The average number of common shares outstanding during the reporting period, calculated by weighting the number of share...
Peer comparison
Standard metric for all public companies; reflects capital structure and share repurchase activity.
Metric ID:
weighted_shares_basicHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 94.6M | 94.7M | 100K | 95.3M | 95.6M | 95.8M | 200K | 97.1M | 97.6M | 97.9M | 200K | 99.8M | 100.8M | 101.1M | 99.7M | 99M | 99.4M | 200K | 100.5M |
| QoQ Change | — | +0.1% | -99.9% | >999% | +0.3% | +0.2% | -99.8% | >999% | +0.5% | +0.3% | -99.8% | >999% | +1.0% | +0.3% | -1.4% | -0.7% | +0.4% | -99.8% | >999% |
| YoY Change | — | — | — | — | +1.1% | +1.2% | +100.0% | +1.9% | +2.1% | +2.2% | +0.0% | +2.8% | +3.3% | +3.3% | -0.1% | -1.8% | -1.7% | — | +0.8% |
Range100K – 101.1M
CAGR+1.4%
Avg YoY Growth+8.2%
Median YoY Growth+1.5%
Shares (Basic) at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's shares (basic)?
- Neurocrine Biosciences (NBIX) reported shares (basic) of 100.5M in Q1 2026.
- How has Neurocrine Biosciences's shares (basic) changed year-over-year?
- Neurocrine Biosciences's shares (basic) increased by 0.8% year-over-year, from 99.7M to 100.5M.
- What is the long-term trend for Neurocrine Biosciences's shares (basic)?
- Over 3 years (2021 to 2025), Neurocrine Biosciences's shares (basic) has grown at a 1.7% compound annual growth rate (CAGR), from 283.6M to 298.3M.
- What does shares (basic) mean?
- The average number of shares held by investors during the period.